Biocompatibility of engineered nanoparticles for drug delivery

Journal of Controlled Release

Volumn 166, Issue 2, 2013, Pages 182-194

  Naahidi, Sheva ^a,b,c,d   Jafari, Mousa ^a,b   Edalat, Faramarz ^c,d   Raymond, Kevin ^a   Khademhosseini, Ali ^c,d,e   Chen, P ^a,b  

^a UNIVERSITY OF WATERLOO   (Canada)

^b UNIVERSITY OF WATERLOO   (Canada)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^e HARVARD UNIVERSITY   (United States)

Author keywords

Biocompatibility; Drug delivery; Immune response; Nanoparticles

Indexed keywords

BIOLOGICAL EFFECTS; BIOLOGICAL ENVIRONMENTS; DRUG DELIVERY APPLICATIONS; DRUG DELIVERY SYSTEM; ENGINEERED NANOPARTICLES; EVALUATION CRITERIA; EXTRACELLULAR ENVIRONMENTS; HUMAN HEALTH; IMMUNE RESPONSE; PHYSICOCHEMICAL CHARACTERISTICS; RAPID ADVANCEMENT; RESEARCH DIRECTIONS; SAFETY GUIDELINES;

BIOCOMPATIBILITY; DRUG DELIVERY; ENZYME ACTIVITY;

NANOPARTICLES;

FULLERENE; GRAPHENE; LIPOSOME; MACROGOL; NANOCARRIER; POLYHYDROXY C60; UNCLASSIFIED DRUG;

ADSORPTION; BIOCOMPATIBILITY; BIODEGRADABILITY; CHEMICAL COMPOSITION; CHEMICAL STRUCTURE; COMPLEMENT SYSTEM; DRUG DELIVERY SYSTEM; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; MOLECULAR INTERACTION; MOLECULAR STABILITY; MOLECULAR WEIGHT; PARTICLE SIZE; PRIORITY JOURNAL; REVIEW; THICKNESS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BIOCOMPATIBLE MATERIALS; DENDRIMERS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; GOVERNMENT AGENCIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIPIDS; MATERIALS TESTING; METALS; NANOPARTICLES; POLYETHYLENE GLYCOLS; POLYMERS; QUANTUM DOTS;

EID: 84873046533     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2012.12.013     Document Type: Review

References (185)

1. B. Padmavathy, R. Vinoth Kumar, and B.M. Jaffar Ali A direct detection of escherichia coli genomic DNA using gold nanoprobes J. Nanobiotechnol. 10 2012 8
2. D. Huo, X. Yi, L. Yanhua, C. Zhijung, G. Huilin, S. Shuxian, S. Yun, and L. Xiaofang Gold nanoparticles with asymetric polymerase chain reaction for colorimetric detection of DNA sequence Anal. Chem. 2012 1253 1258
3. S. Guerrero, R. Herance, S. Rojas, J. Mena, J. Gispert, G. Acosta, P. Albericio, and M.J. Kogan Synthesis and in vivo evaluation of the biodistribution of a 18 F labelled conjugate gold-nanoparticle-peptide with potential biomedical application Bioconjug. Chem. 23 2012 399 408
4. W.S. Kuo, Y.T. Chang, K.C. Cho, K.C. Chiu, C.H. Lien, C.S. Yeh, and S.J. Chen Gold nanomaterials conjugated with indocyanine green for dual-modality photodynamic and photothermal therapy Biomaterials 33 2012 3270 3278
5. M. Law, M. Jafari, and P. Chen Physicochemical characterization of siRNA-peptide complexes Biotechnol. Prog. 24 2008 957 963
6. M. Jafari, and P. Chen Peptide mediated siRNA delivery Curr. Top. Med. Chem. 9 2009 1088 1097
7. M. Jafari, M. Soltani, S. Naahidi, N. Karunaratne, and P. Chen Nonviral approach for targeted nucleic acid delivery Curr. Med. Chem. 19 2012 197 208
8. H.C. Fischer, and W.C. Chan Nanotoxicity: the growing need for in vivo study Curr. Opin. Biotechnol. 18 2007 565 571
9. M. Goldberg, R. Langer, and X. Jia Nanostructured materials for applications in drug delivery and tissue engineering J. Biomater. Sci. Polym. Ed. 18 2007 241
10. D.F. Williams On the mechanisms of biocompatibility Biomaterials 29 2008 2941 2953
11. D.S. Kohane, and R. Langer Biocompatibility and drug delivery systems Chem. Sci. 1 2010 441 446
12. M.A. Dobrovolskaia, and S.E. McNeil Immunological properties of engineered nanomaterials Nat. Nanotechnol. 2 2007 469 478
13. M.A. Dobrovolskaia, P. Aggarwal, J.B. Hall, and S.E. McNeil Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution Mol. Pharm. 5 2008 487 495
14. P. Aggarwal, J.B. Hall, C.B. McLeland, M.A. Dobrovolskaia, and S.E. McNeil Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy Adv. Drug Deliv. Rev. 61 2009 428 437
15. J. Wang, J. Chen, N. Ye, Z. Luo, W. Lai, X. Cai, and Y. Lin Absorption, pharmacokinetics and disposition properties of solid lipid nanoparticles (SLNs) Curr. Drug Metab. 13 2012 447 456
16. H.M. Patel Serum opsonins and liposomes: their interaction and opsonophagocytosis Crit. Rev. Ther. Drug Carrier Syst. 9 1992 39 90
17. L. Aschoff Das reticuloendotheliale system Ergeb. Inn. Med. Kinderheilkd. 26 1924 1 118
18. R. van Furth, Z.A. Cohn, J.G. Hirsch, J.H. Humphrey, W.G. Spector, and H.L. Langevoort The mononuclear phagocyte system: a new classification of macrophages, monocytes, and their precursor cells Bull. World Health Organ. 46 1972 845 852
19. R. van Furth Mononuclear Phagocytes 1970 Blackwell Scientific Publications Oxford
20. K. Takahashi Development and differentiation of macrophages and related cells: historical revew and current concepts J. Clin. Exp. Hematopathol. 41 2001 1 33
21. D.E. Owens III, and N.A. Peppas Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles Int. J. Pharm. 307 2006 93 102
22. A. Chonn, S.C. Semple, and P.R. Cullis Association of blood proteins with large unilamellar liposomes in vivo. relation to circulation lifetimes J. Biol. Chem. 267 1992 18759 18765
23. H. Kiwada, T. Miyajima, and Y. Kato Studies on the uptake mechanism of liposomes by perfused rat liver. II. an indispensable factor for liver uptake in serum Chem. Pharm. Bull. (Tokyo) 35 1987 1189 1195
24. T.M. Goppert, and R.H. Muller Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: comparison of plasma protein adsorption patterns J. Drug Target. 13 2005 179 187
25. A. Kumari, S.K. Yadav, and S.C. Yadav Biodegradable polymeric nanoparticles based drug delivery systems Colloids Surf. B 75 2010 1 18
26. D.M. Brown, M.R. Wilson, W. MacNee, V. Stone, and K. Donaldson Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines Toxicol. Appl. Pharmacol. 175 2001 191 199
27. K. Donaldson, D. Brown, A. Clouter, R. Duffin, W. MacNee, L. Renwick, L. Tran, and V. Stone The pulmonary toxicology of ultrafine particles J. Aerosol Med. 15 2002 213 220
28. K. Donaldson, and L. Ultrafine (nanometre) particle mediated lung injury J. Aerosol Sci. 29 1998 553 560
29. G. Oberdorster, J. Ferin, R. Gelein, S.C. Soderholm, and J. Finkelstein Role of the alveolar macrophage in lung injury: studies with ultrafine particles Environ. Health Perspect. 97 1992 193 199
30. C.L. Tran, D. Buchanan, R.T. Cullen, A. Searl, A.D. Jones, and K. Donaldson Inhalation of poorly soluble particles. II. influence of particle surface area on inflammation and clearance Inhal. Toxicol. 12 2000 1113 1126
31. A.E. Nel, L. Madler, D. Velegol, T. Xia, E.M. Hoek, P. Somasundaran, F. Klaessig, V. Castranova, and M. Thompson Understanding biophysicochemical interactions at the nano-bio interface Nat. Mater. 8 2009 543 557
32. L.G. Donaruma Definitions in biomaterials D.F. Williams, J. Polym. Sci.: Polym. Lett. Ed. 26 1987 Elsevier Amsterdam 414 422
33. D.F. Williams The Williams Dictionary of Biomaterials 1999 Liverpool University Press Liverpool
34. J.M. Anderson, A. Rodriguez, and D.T. Chang Foreign body reaction to biomaterials Semin. Immunol. 20 2008 86 100
35. R. Nicolete, D.F. dos Santos, and L.H. Faccioli The uptake of PLGA micro or nanoparticles by macrophages provokes distinct in vitro inflammatory response Int. Immunopharmacol. 11 2011 1557 1563
36. W. Jiang, R.K. Gupta, M.C. Deshpande, and S.P. Schwendeman Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens Adv. Drug Deliv. Rev. 57 2005 391 410
37. S. Liu, R. Maheshwari, and K.L. Kiick Polymer-based therapeutics Macromolecules 42 2009 3 13
38. B. Fadeel, and A.E. Garcia-Bennett Better safe than sorry: understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications Adv. Drug Deliv. Rev. 62 2010 362 374
39. D.T. O'Hagan, and M. Singh Microparticles as vaccine adjuvants and delivery systems Expert Rev. Vaccines 2 2003 269 283
40. R.C. Mundargi, V.R. Babu, V. Rangaswamy, P. Patel, and T.M. Aminabhavi Nano/micro technologies for delivering macromolecular therapeutics using poly(D, L-lactide-co-glycolide) and its derivatives J. Control. Release 125 2008 193 209
41. Y. Men, R. Audran, C. Thomasin, G. Eberl, S. Demotz, H.P. Merkle, B. Gander, and G. Corradin MHC class I- and class II-restricted processing and presentation of microencapsulated antigens Vaccine 17 1999 1047 1056
42. A.M. Carcaboso, R.M. Hernandez, M. Igartua, J.E. Rosas, M.E. Patarroyo, and J.L. Pedraz Potent, long lasting systemic antibody levels and mixed Th1/Th2 immune response after nasal immunization with malaria antigen loaded PLGA microparticles Vaccine 22 2004 1423 1432
43. Y. Tabata, and Y. Ikada Macrophage phagocytosis of biodegradable microspheres composed of L-lactic acid/glycolic acid homo- and copolymers J. Biomed. Mater. Res. 22 1988 837 858
44. J.H. Eldridge, J.K. Staas, J.A. Meulbroek, J.R. McGhee, T.R. Tice, and R.M. Gilley Biodegradable microspheres as a vaccine delivery system Mol. Immunol. 28 1991 287 294
45. L. Thiele, B. Rothen-Rutishauser, S. Jilek, H. Wunderli-Allenspach, H.P. Merkle, and E. Walter Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages? J. Control. Release 76 2001 59 71
46. I. Gutierro, R.M. Hernandez, M. Igartua, A.R. Gascon, and J.L. Pedraz Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres Vaccine 21 2002 67 77
47. C.S. Chong, M. Cao, W.W. Wong, K.P. Fischer, W.R. Addison, G.S. Kwon, D.L. Tyrrell, and J. Samuel Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery J. Control. Release 102 2005 85 99
48. F. Danhier, E. Ansorena, J.M. Silva, R. Coco, A. Le Breton, and V. Preat PLGA-based nanoparticles: an overview of biomedical applications J. Control. Release 161 2012 505 522
49. T. Nakamura, S. Hitomi, S. Watanabe, Y. Shimizu, K. Jamshidi, S.H. Hyon, and Y. Ikada Bioabsorbtion of polylactides with different molecular properties Biomed. Mater. 23 1989 1115 1130
50. J. Descotes Importance of immunotoxicity in safety assessment: a medical toxicologist's perspective Toxicol. Lett. 149 2004 103 108
51. P. Chamberlain, and A.R. Mire-Sluis An overview of scientific and regulatory issues for the immunogenicity of biological products Dev. Biol. (Basel) 112 2003 3 11
52. B. Říhová Biocompatibility and immunocompatibility of water- soluble polymers based on HPMA Composites Part B 38 2007 386 397
53. F. Stieneker, J. Kreuter, and J. Lower High antibody titres in mice with polymethylmethacrylate nanoparticles as adjuvant for HIV vaccines AIDS 5 1991 431 435
54. A. Caputo, E. Brocca-Cofano, A. Castaldello, R. De Michele, G. Altavilla, M. Marchisio, R. Gavioli, U. Rolen, L. Chiarantini, A. Cerasi, S. Dominici, M. Magnani, A. Cafaro, K. Sparnacci, M. Laus, L. Tondelli, and B. Ensoli Novel biocompatible anionic polymeric microspheres for the delivery of the HIV-1 tat protein for vaccine application Vaccine 22 2004 2910 2924
55. R. Voltan, A. Castaldello, E. Brocca-Cofano, G. Altavilla, A. Caputo, M. Laus, K. Sparnacci, B. Ensoli, S. Spaccasassi, M. Ballestri, and L. Tondelli Preparation and characterization of innovative protein-coated poly(methylmethacrylate) core-shell nanoparticles for vaccine purposes Pharm. Res. 24 2007 1870 1882
56. K. Sparnacci, M. Laus, L. Tondelli, C. Bernardi, L. Magnani, F. Corticelli, M. Marchisio, B. Ensoli, A. Castaldello, and A. Caputo Core-shell microspheres by dispersion polymerization as promising delivery systems for proteins J. Biomater. Sci. Polym. Ed. 16 2005 1557 1574
57. A. Caputo, A. Castaldello, E. Brocca-Cofano, R. Voltan, F. Bortolazzi, G. Altavilla, K. Sparnacci, M. Laus, L. Tondelli, R. Gavioli, and B. Ensoli Induction of humoral and enhanced cellular immune responses by novel core-shell nanosphere- and microsphere-based vaccine formulations following systemic and mucosal administration Vaccine 27 2009 3605 3615
58. A. Caputo, R. Gavioli, and B. Ensoli Recent advances in the development of HIV-1 tat-based vaccines Curr. HIV Res. 2 2004 357 376
59. E. Fanales-Belasio, A. Cafaro, A. Cara, D.R. Negri, V. Fiorelli, S. Butto, S. Moretti, M.T. Maggiorella, S. Baroncelli, Z. Michelini, A. Tripiciano, L. Sernicola, A. Scoglio, A. Borsetti, B. Ridolfi, R. Bona, P. Ten Haaft, I. Macchia, P. Leone, M.R. Pavone-Cossut, F. Nappi, E. Vardas, M. Magnani, E. Laguardia, A. Caputo, F. Titti, and B. Ensoli HIV-1 tat-based vaccines: from basic science to clinical trials DNA Cell Biol. 21 2002 599 610
60. N. Castignolles, S. Morgeaux, C. Gontier-Jallet, D. Samain, D. Betbeder, and P. Perrin A new family of carriers (biovectors) enhances the immunogenicity of rabies antigens Vaccine 14 1996 1353 1360
61. M. Diwan, P. Elamanchili, H. Lane, A. Gainer, and J. Samuel Biodegradable nanoparticle mediated antigen delivery to human cord blood derived dendritic cells for induction of primary T cell responses J. Drug Target. 11 2003 495 507
62. Z. Cui, S.J. Han, D.P. Vangasseri, and L. Huang Immunostimulation mechanism of LPD nanoparticle as a vaccine carrier Mol. Pharm. 2 2005 22 28
63. Y. Tan, S. Li, B.R. Pitt, and L. Huang The inhibitory role of CpG immunostimulatory motifs in cationic lipid vector-mediated transgene expression in vivo Hum. Gene Ther. 10 1999 2153 2161
64. M. Diwan, P. Elamanchili, M. Cao, and J. Samuel Dose sparing of CpG oligodeoxynucleotide vaccine adjuvants by nanoparticle delivery Curr. Drug Deliv. 1 2004 405 412
65. Z. Cui, C.H. Hsu, and R.J. Mumper Physical characterization and macrophage cell uptake of mannan-coated nanoparticles Drug Dev. Ind. Pharm. 29 2003 689 700
66. R.A. Garibaldi Infections in organ transplant recipients Infect. Control 4 1998 460
67. T. Vial, and J. Descotes Immunosuppressive drugs and cancer Toxicology 185 2003 229 240
68. S. Shaunak, S. Thomas, E. Gianasi, A. Godwin, E. Jones, I. Teo, K. Mireskandari, P. Luthert, R. Duncan, S. Patterson, P. Khaw, and S. Brocchini Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation Nat. Biotechnol. 22 2004 977 984
69. W.U. Kim, W.K. Lee, J.W. Ryoo, S.H. Kim, J. Kim, J. Youn, S.Y. Min, E.Y. Bae, S.Y. Hwang, S.H. Park, C.S. Cho, J.S. Park, and H.Y. Kim Suppression of collagen-induced arthritis by single administration of poly(lactic-co-glycolic acid) nanoparticles entrapping type II collagen: a novel treatment strategy for induction of oral tolerance Arthritis Rheum. 46 2002 1109 1120
70. M. Higaki, T. Ishihara, N. Izumo, M. Takatsu, and Y. Mizushima Treatment of experimental arthritis with poly(D, L-lactic/glycolic acid) nanoparticles encapsulating betamethasone sodium phosphate Ann. Rheum. Dis. 64 2005 1132 1136
71. A. Basarkar, and J. Singh Poly (lactide-co-glycolide)-polymethacrylate nanoparticles for intramuscular delivery of plasmid encoding interleukin-10 to prevent autoimmune diabetes in mice Pharm. Res. 26 2009 72 81
72. J.R. Cromer, S.J. Wood, K.A. Miller, T. Nguyen, and S.A. David Functionalized dendrimers as endotoxin sponges Bioorg. Med. Chem. Lett. 15 2005 1295 1298
73. J.J. Ryan, H.R. Bateman, A. Stover, G. Gomez, S.K. Norton, W. Zhao, L.B. Schwartz, R. Lenk, and C.L. Kepley Fullerene nanomaterials inhibit the allergic response J. Immunol. 179 2007 665 672
74. N.A. Balenga, F. Zahedifard, R. Weiss, M.N. Sarbolouki, J. Thalhamer, and S. Rafati Protective efficiency of dendrosomes as novel nano-sized adjuvants for DNA vaccination against birch pollen allergy J. Biotechnol. 124 2006 602 614
75. S. Gomez, C. Gamazo, B. San Roman, M. Ferrer, M.L. Sanz, S. Espuelas, and J.M. Irache Allergen immunotherapy with nanoparticles containing lipopolysaccharide from brucella ovis Eur. J. Pharm. Biopharm. 70 2008 711 717
76. K. Roy, H.Q. Mao, S.K. Huang, and K.W. Leong Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy Nat. Med. 5 1999 387 391
77. I. Scholl, A. Weissenbock, E. Forster-Waldl, E. Untersmayr, F. Walter, M. Willheim, G. Boltz-Nitulescu, O. Scheiner, F. Gabor, and E. Jensen-Jarolim Allergen-loaded biodegradable poly(D, L-lactic-co-glycolic) acid nanoparticles down-regulate an ongoing Th2 response in the BALB/c mouse model Clin. Exp. Allergy 34 2004 315 321
78. S. Gomez, C. Gamazo, B.S. Roman, M. Ferrer, M.L. Sanz, and J.M. Irache Gantrez AN nanoparticles as an adjuvant for oral immunotherapy with allergens Vaccine 25 2007 5263 5271
79. N.S. Zogovic, N.S. Nikolic, S. Vranjes-Djuric, L.M. Harhaji, L.M. Vucicevic, K.D. Janjetovic, M.S. Misirkic, B. Todorovic-Markovic, Z.M. Markovic, S.K. Milonjic, and V.S. Trajkovic Opposite effects of nanocrystalline fullerene (C(60)) on tumour cell growth in vitro and in vivo and a possible role of immunosupression in the cancer-promoting activity of C(60) Biomaterials 30 2009 6940
80. A. Abuchowski, T. van Es, N.C. Palczuk, and F.F. Davis Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol J. Biol. Chem. 252 1977 3578 3581
81. P.G. de Gennes Conformation of polymers attached to an interface Macromolecules 13 1980 1069 1075
82. J.V. Jokerst, T. Lobovkina, R.N. Zare, and S.S. Gambhir Nanoparticle PEGylation for imaging and therapy Nanomedicine (Lond.) 6 2011 715 728
83. C. Allen, N. Dos Santos, R. Gallagher, G.N. Chiu, Y. Shu, W.M. Li, S.A. Johnstone, A.S. Janoff, L.D. Mayer, M.S. Webb, and M.B. Bally Controlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol) Biosci. Rep. 22 2002 225 250
84. R. Gref, Y. Minamitake, M.T. Peracchia, V. Trubetskoy, V. Torchilin, and R. Langer Biodegradable long-circulating polymeric nanospheres Science 263 1994 1600 1603
85. J.S. Tan, D.E. Butterfield, C.L. Voycheck, K.D. Caldwell, and J.T. Li Surface modification of nanoparticles by PEO/PPO block copolymers to minimize interactions with blood components and prolong blood circulation in rats Biomaterials 14 1993 823 833
86. A.L. Klibanov, K. Maruyama, V.P. Torchilin, and L. Huang Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes FEBS Lett. 268 1990 235 237
87. K. Kataoka, A. Harada, and Y. Nagasaki Block copolymer micelles for drug delivery: design, characterization and biological significance Adv. Drug Deliv. Rev. 47 2001 113 131
88. A. Abuchowski, J.R. McCoy, N.C. Palczuk, T. van Es, and F.F. Davis Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase J. Biol. Chem. 252 1977 3582 3586
89. G. Molineux Pegylation: Engineering improved biopharmaceuticals for oncology Pharmacotherapy 23 2003 3S 8S
90. D.L. Elbert, and J.A. Hubbell Surface treatments of polymers for biocompatibility Ann. Rev. Mater. Sci. 26 1996 365 394
91. J.H. Lee, H.B. Lee, and J.D. Andrade Blood compatibility of polyethylene oxide surfaces Prog. Polym. Sci. 20 1995 1043 1079
92. V.P. Torchilin, and M.I. Papisov Why do polyethylene glycol-coated liposomes circulate so long? J. Liposome Res. 4 1994 725 739
93. D. Needham, and D.H. Kim PEG-covered lipid surfaces: Bilayers and monolayers Colloids Surf., B 18 2000 183 195
94. P.L. Ahl, S.K. Bhatia, P. Meers, P. Roberts, R. Stevens, R. Dause, W.R. Perkins, and A.S. Janoff Enhancement of the in vivo circulation lifetime of L-alpha-distearoylphosphatidylcholine liposomes: Importance of liposomal aggregation versus complement opsonization Biochim. Biophys. Acta 1329 1997 370 382
95. S.M. Moghimi, I.S. Muir, L. Illum, S.S. Davis, and V. Kolb-Bachofen Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum Biochim. Biophys. Acta 1179 1993 157 165
96. M. Vert, and D. Domurado Poly(ethylene glycol): Protein-repulsive or albumin-compatible? J. Biomater. Sci. Polym. Ed. 11 2000 1307 1317
97. S.R. Sheth, and D. Leckband Measurements of attractive forces between proteins and end-grafted poly(ethylene glycol) chains Proc. Natl. Acad. Sci. U. S. A. 94 1997 8399 8404
98. C. Chen, Y.C. Cheng, C.H. Yu, S.W. Chan, M.K. Cheung, and P.H. Yu. In vitro cytotoxicity, hemolysis assay, and biodegradation behavior of biodegradable poly(3-hydroxybutyrate)-poly(ethylene glycol)-poly(3- hydroxybutyrate) nanoparticles as potential drug carriers J. Biomed. Mater. Res. A 87 2008 290 298
99. B. Rihova, and M. Kovar Immunogenicity and immunomodulatory properties of HPMA-based polymers Adv. Drug Deliv. Rev. 62 2010 184 191
100. C. Salvador-Morales, E. Flahaut, E. Sim, J. Sloan, M.L. Green, and R.B. Sim Complement activation and protein adsorption by carbon nanotubes Mol. Immunol. 43 2006 193 201
101. D.M. Domanski, B. Klajnert, and M. Bryszewska Influence of PAMAM dendrimers on human red blood cells Bioelectrochemistry 63 2004 189 191
102. J.F. Bermejo, P. Ortega, L. Chonco, R. Eritja, R. Samaniego, M. Mullner, E. de Jesus, F.J. de la Mata, J.C. Flores, R. Gomez, and A. Munoz-Fernandez Water-soluble carbosilane dendrimers: Synthesis biocompatibility and complexation with oligonucleotides; evaluation for medical applications Chemistry 13 2007 483 495
103. H.B. Agashe, T. Dutta, M. Garg, and N.K. Jain Investigations on the toxicological profile of functionalized fifth-generation poly (propylene imine) dendrimer J. Pharm. Pharmacol. 58 2006 1491 1498
104. T. Dutta, H.B. Agashe, M. Garg, P. Balakrishnan, M. Kabra, and N.K. Jain Poly (propyleneimine) dendrimer based nanocontainers for targeting of efavirenz to human monocytes/macrophages in vitro J. Drug Target. 15 2007 89 98
105. N. Malik, R. Wiwattanapatapee, R. Klopsch, K. Lorenz, H. Frey, J.W. Weener, E.W. Meijer, W. Paulus, and R. Duncan Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo J. Control. Release 65 2000 133 148
106. D.S. Shah, T. Sakthivel, I. Toth, A.T. Florence, and A.F. Wilderspin DNA transfection and transfected cell viability using amphipathic asymmetric dendrimers Int. J. Pharm. 208 2000 41 48
107. J. Tan, A. Thomas, and Y. Liu Influence of red blood cells on nanoparticle targeted delivery in microcirculation Soft Matter 8 2011 1934 1946
108. L.L. Munn, R.J. Melder, and R.K. Jain Role of erythrocytes in leukocyte-endothelial interactions: mathematical model and experimental validation Biophys. J. 71 1996 466 478
109. C. Migliorini, Y. Qian, H. Chen, E.B. Brown, R.K. Jain, L.L. Munn, C. Migliorini, Y. Qian, H. Chen, E.B. Brown, R.K. Jain, and L.L. Munn Red blood cells augment leukocyte rolling in a virtual blood vessel Biophys. J. 83 2002 1834 1841
110. C. Sun, C. Migliorini, and L.L. Munn Red blood cells initiate leukocyte rolling in postcapillary expansions: a lattice boltzmann analysis Biophys. J. 85 2003 208 222
111. C. Salvador-Morales, L. Zhang, R. Langer, and O.C. Farokhzad Immunocompatibility properties of lipid-polymer hybrid nanoparticles with heterogeneous surface functional groups Biomaterials 30 2009 2231 2240
112. G. Storm, S.O. Belliot, T. Daemen, and D.D. Lasic Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system Adv. Drug Deliv. Rev. 17 1995 31 48
113. U.M. Dhana Lekshmi, G. Poovi, N. Kishore, and P.N. Reddy In vitro characterization and invivo toxicity study of repaglinide loaded poly (methyl methacrylate) nanoparticles Int. J. Pharm. 396 2010 194 203
114. A. Mahapatro, and D.K. Singh Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines J. Nanobiotechnol. 9 2011 55
115. J.X. Lu, A. Gallur, B. Flautre, K. Anselme, M. Descamps, B. Thierry, and P. Hardouin Comparative study of tissue reactions to calcium phosphate ceramics among cancellous, cortical, and medullar bone sites in rabbits J. Biomed. Mater. Res. 42 1998 357 367
116. G. Daculsi, R.Z. LeGeros, M. Heughebaert, and I. Barbieux Formation of carbonate-apatite crystals after implantation of calcium phosphate ceramics Calcif. Tissue Int. 46 1990 20 27
117. M.A. Dobrovolskaia, D.R. Germolec, and J.L. Weaver Evaluation of nanoparticle immunotoxicity Nat. Nanotechnol. 4 2009 411 414
118. C. Buzea, I.I. Pacheco, and K. Robbie Nanomaterials and nanoparticles: Sources and toxicity Biointerphases 2 2007 MR17-71
119. F. Klaessig, M. Marrapese, and S. Abe Current perspectives in nanotechnology terminology and nomenclature V. Murashov, J. Howard, Nanostructure Science and Technology 2011 Springer Science+Business Media NY 21 52
120. L. Broers Nanotechnologies and Food 2010 The Stationery Office Limited London
121. W.H. De Jong, and P.J. Borm Drug delivery and nanoparticles:Applications and hazards Int. J. Nanomed. 3 2008 133 149
122. S.M. Moghimi, A.C. Hunter, and J.C. Murray Nanomedicine: current status and future prospects FASEB J. 19 2005 311 330
123. K. Cho, X. Wang, S. Nie, Z.G. Chen, and D.M. Shin Therapeutic nanoparticles for drug delivery in cancer Clin. Cancer Res. 14 2008 1310 1316
124. S.R. Shin, H. Bae, J.M. Cha, J.Y. Mun, Y.C. Chen, H. Tekin, H. Shin, S. Farshchi, M.R. Dokmeci, S. Tang, and A. Khademhosseini Carbon nanotube reinforced hybrid microgels as scaffold materials for cell encapsulation ACS Nano 6 2012 362 372
125. K. Pulskamp, S. Diabate, and H.F. Krug Carbon nanotubes show no sign of acute toxicity but induce intracellular reactive oxygen species in dependence on contaminants Toxicol. Lett. 168 2007 58 74
126. X. Zhang, L. Meng, Q. Lu, Z. Fei, and P.J. Dyson Targeted delivery and controlled release of doxorubicin to cancer cells using modified single wall carbon nanotubes Biomaterials 30 2009 6041 6047
127. H. Ren, X. Chen, J. Liu, N. Gu, and X. Huang Toxicity of single- walled carbon nanotube: how we were wrong? Mater. Today 13 2010 6 8
128. N. Saito, Y. Usui, K. Aoki, N. Narita, M. Shimizu, K. Hara, N. Ogiwara, K. Nakamura, N. Ishigaki, H. Kato, S. Taruta, and M. Endo Carbon nanotubes: biomaterial applications Chem. Soc. Rev. 38 2009 1897 1903
129. X. Li, Y. Fan, and F. Watari Current investigations into carbon nanotubes for biomedical application Biomed. Mater. 5 2010 22001
130. N. Sinha, and J.T.W. Yeow Carbon nanotubes for biomedical applications IEEE Trans. Nanobiosci. 4 2005 180
131. S. Polizu, O. Savadogo, P. Poulin, and L. Yahia Applications of carbon nanotubes-based biomaterials in biomedical nanotechnology J. Nanosci. Nanotechnol. 6 2006 1883 1904
132. C. Lu, H. Yang, C. Zhu, X. Chen, G. Chen, C. Lu, H. Yang, C. Zhu, X. Chen, and G. Chen A graphene platform for sensing biomolecules Angew. Chem. Int. Ed. 48 2009 4785 4787
133. Y. Liu, D. Yu, C. Zeng, Z. Miao, and L. Dai Biocompatible graphene oxide-based glucose biosensors Langmuir 26 2010 6158 6160
134. X. Sun, Z. Liu, K. Welsher, J.T. Robinson, A. Goodwin, S. Zaric, and H. Dai Nano-graphene oxide for cellular imaging and drug delivery Nano Res. 1 2008 203 212
135. W. Hu, C. Peng, W. Luo, M. Lv, X. Li, D. Li, Q. Huang, and C. Fan Graphene-based antibacterial paper ACS Nano 4 2010 4317 4323
136. W. Zhang, Z. Guo, D. Huang, Z. Liu, X. Guo, and H. Zhong Synergistic effect of chemo-photothermal therapy using PEGylated graphene oxide Biomaterials 32 2011 8555 8561
137. K. Yang, S. Zhang, G. Zhang, X. Sun, S. Lee, Z. Liu, K. Yang, S. Zhang, G. Zhang, X. Sun, S. Lee, and Z. Liu Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy Nano Lett. 10 2010 3318
138. L. Yan, Y. Wang, X. Xu, C. Zeng, J. Hou, M. Lin, J. Xu, F. Sun, X. Huang, L. Dai, F. Lu, and Y. Liu Can graphene oxide cause damage to eyesight? Chem. Res. Toxicol. 25 2012 1265 1270
139. Y. Chang, S.T. Yang, J.H. Liu, E. Dong, Y. Wang, A. Cao, Y. Liu, and H. Wang In vitro toxicity evaluation of graphene oxide on A549 cells Toxicol. Lett. 200 2011 201 210
140. H. Chen, M.B. Müller, K.J. Gilmore, G.G. Wallace, and D. Li Mechanically strong, electrically conductive, and biocompatible graphene paper Adv. Mater. 20 2008 3557 3561
141. S. Park, N. Mohanty, J.W. Suk, A. Nagaraja, J. An, R.D. Piner, W. Cai, D.R. Dreyer, V. Berry, and R.S. Ruoff Biocompatible, robust free-standing paper composed of a TWEEN/graphene composite Adv. Mater. 22 2010 1736 1740
142. K. Liao, Y. Lin, C.W. Macosko, and C.L. Haynes Cytotoxicity of graphene oxide and graphene in human erythrocytes and skin fibroblasts ACS Appl. Mater. Interfaces 3 2011 2607 2615
143. N.V. Vallabani, S. Mittal, R.K. Shukla, A.K. Pandey, S.R. Dhakate, R. Pasricha, and A. Dhawan Toxicity of graphene in normal human lung cells (BEAS-2B) J. Biomed. Nanotechnol. 7 2011 106 107
144. K. Wang, J. Ruan, H. Song, J. Zhang, Y. Wo, S. Guo, and D. Cui Biocompatibility of graphene oxide Nanoscale Res. Lett. 6 2011 1 8
145. S.Y. Madani, N. Naderi, O. Dissanayake, A. Tan, A.M. Seifalian, S.Y. Madani, N. Naderi, O. Dissanayake, A. Tan, and A.M. Seifalian A new era of cancer treatment: Carbon nanotubes as drug delivery tools Int. J. Nanomed. 6 2011 2963
146. S. Brocchini, and R. Duncan Encyclopaedia of Controlled Drug Delivery 1999 Wiley New York 786
147. L. Qiu, Y. Bae, Y. Bae, and H. Bae Polymer architecture and drug delivery Pharm. Res. 23 2006 1 30
148. R. Duncan The dawning era of polymer therapeutics Nat. Rev. Drug Discov. 2 2003 347 360
149. J.G. Shiah, Y. Sun, P. Kopeckova, C.M. Peterson, R.C. Straight, and J. Kopecek Combination chemotherapy and photodynamic therapy of targetable N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin/mesochlorin e(6)-OV-TL 16 antibody immunoconjugates J. Control. Release 74 2001 249 253
150. X. Li, Z. Yang, K. Yang, Y. Zhou, X. Chen, Y. Zhang, F. Wang, Y. Liu, and L. Ren Self-assembled polymeric micellar nanoparticles as nanocarriers for poorly soluble anticancer drug ethaselen Nanoscale Res. Lett. 4 2009 1502 1511
151. S.A. Wissing, O. Kayser, and R.H. Muller Solid lipid nanoparticles for parenteral drug delivery Adv. Drug Deliv. Rev. 56 2004 1257 1272
152. Y. Wang, J. Robertson, L. Spillman, W. Claus, B. Claus, R. Claus, and O. Claus Effects of the chemical structure and the surface properties of polymeric biomaterials on their biocompatibility Pharm. Res. 21 2004 1362 1373
153. F. Danhier, N. Lecouturier, B. Vroman, C. Jerome, J. Marchand-Brynaert, O. Feron, and V. Preat Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation J. Control. Release 133 2009 11 17
154. X. Xu, and S.A. Asher Synthesis and utilization of monodisperse hollow polymeric particles in photonic crystals J. Am. Chem. Soc. 126 2004 7940 7945
155. E.K. Efthimiadou, L.A. Tziveleka, P. Bilalis, and G. Kordas Novel PLA modification of organic microcontainers based on ring opening polymerization: Synthesis, characterization, biocompatibility and drug loading/release properties Int. J. Pharm. 428 2012 134 142
156. D. Peer, J.M. Karp, S. Hong, O.C. Farokhzad, R. Margalit, and R. Langer Nanocarriers as an emerging platform for cancer therapy Nat. Nanotechnol. 2 2007 751 760
157. B.S. Kim, S.W. Park, and P.T. Hammond Hydrogen-bonding layer-by-layer-assembled biodegradable polymeric micelles as drug delivery vehicles from surfaces ACS Nano 2 2008 386 392
158. B.S. Kim, R.C. Smith, Z. Poon, and P.T. Hammond MAD (multiagent delivery) nanolayer: delivering multiple therapeutics from hierarchically assembled surface coatings Langmuir 25 2009 14086 14092
159. J. Yang, J. Choi, D. Bang, E. Kim, E.K. Lim, H. Park, J.S. Suh, K. Lee, K.H. Yoo, E.K. Kim, Y.M. Huh, and S. Haam Convertible organic nanoparticles for near-infrared photothermal ablation of cancer cells Angew. Chem. Int. Ed. Engl. 50 2011 441 444
160. J. Liu, Y. Pang, W. Huang, X. Huang, L. Meng, X. Zhu, Y. Zhou, and D. Yan Bioreducible micelles self-assembled from amphiphilic hyperbranched multiarm copolymer for glutathione-mediated intracellular drug delivery Biomacromolecules 12 2011 1567 1577
161. T. Ta, A.J. Convertine, C.R. Reyes, P.S. Stayton, and T.M. Porter Thermosensitive liposomes modified with poly(N-isopropylacrylamide-co- propylacrylic acid) copolymers for triggered release of doxorubicin Biomacromolecules 11 2010 1915 1920
162. J.Z. Du, X.J. Du, C.Q. Mao, and J. Wang Tailor-made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug delivery J. Am. Chem. Soc. 133 2011 17560 17563
163. S. Lee, K. Saito, H.R. Lee, M.J. Lee, Y. Shibasaki, Y. Oishi, and B.S. Kim Hyperbranched double hydrophilic block copolymer micelles of poly(ethylene oxide) and polyglycerol for pH-responsive drug delivery Biomacromolecules 13 2012 1190 1196
164. Y. Bae, and K. Kataoka Intelligent polymeric micelles from functional poly(ethylene glycol)-poly(amino acid) block copolymers Adv. Drug Deliv. Rev. 61 2009 768 784
165. Y. Bae, S. Fukushima, A. Harada, and K. Kataoka Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: Polymeric micelles that are responsive to intracellular pH change Angew. Chem. Int. Ed. Engl. 42 2003 4640 4643
166. Y. Bae, N. Nishiyama, S. Fukushima, H. Koyama, M. Yasuhiro, and K. Kataoka Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy Bioconjug. Chem. 16 2005 122 130
167. X. Yang, J.J. Grailer, I.J. Rowland, A. Javadi, S.A. Hurley, V.Z. Matson, D.A. Steeber, and S. Gong Multifunctional stable and pH-responsive polymer vesicles formed by heterofunctional triblock copolymer for targeted anticancer drug delivery and ultrasensitive MR imaging ACS Nano 4 2010 6805 6817
168. B.S. Kim, H.I. Lee, Y. Min, Z. Poon, and P.T. Hammond Hydrogen-bonded multilayer of pH-responsive polymeric micelles with tannic acid for surface drug delivery Chem. Commun. (Camb.) 28 2009 4194 4196
169. R. Tang, W. Ji, D. Panus, R.N. Palumbo, and C. Wang Block copolymer
170. B.S. Zolnik, and N. Sadrieh Regulatory perspective on the importance of ADME assessment of nanoscale material containing drugs Adv. Drug Deliv. Rev. 61 2009 422 427
171. L. Zhang, F.X. Gu, J.M. Chan, A.Z. Wang, R.S. Langer, and O.C. Farokhzad Nanoparticles in medicine: therapeutic applications and developments Clin. Pharmacol. Ther. 83 2008 761 769
172. T. Nakanishi, J. Kunisawa, A. Hayashi, Y. Tsutsumi, K. Kubo, S. Nakagawa, M. Nakanishi, K. Tanaka, and T. Mayumi Positively charged liposome functions as an efficient immunoadjuvant in inducing cell-mediated immune response to soluble proteins J. Control. Release 61 1999 233 240
173. A.J. Almeida, and E. Souto Solid lipid nanoparticles as a drug delivery system for peptides and proteins Adv. Drug Deliv. Rev. 59 2007 478 490
174. W. Mehnert, and K. Mader Solid lipid nanoparticles: Production, characterization and applications Adv. Drug Deliv. Rev. 47 2001 165 196
175. R.H. Muller, K. Mader, and S. Gohla Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art Eur. J. Pharm. Biopharm. 50 2000 161 177
176. J. Qi, Y. Lu, and W.Wu. Absorption disposition and pharmacokinetics of solid lipid nanoparticles Curr. Drug Metab. 13 2012 418 428
177. P. Juzenas, W. Chen, Y.P. Sun, M.A. Coelho, R. Generalov, N. Generalova, and I.L. Christensen Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer Adv. Drug Deliv. Rev. 60 2008 1600 1614
178. C.E. Probst, P. Zrazhevskiy, V. Bagalkot, and X. Gao Quantum dots as a platform for nanoparticle drug delivery vehicle design Adv. Drug Deliv. Rev. 2012 10.1016/j.addr.2012.09.036 In press
179. T.S. Hauck, R.E. Anderson, H.C. Fischer, S. Newbigging, and W.C. Chan In vivo quantum-dot toxicity assessment Small 6 2010 138 144
180. L. Ye, K.T. Yong, L. Liu, I. Roy, R. Hu, J. Zhu, H. Cai, W.C. Law, J. Liu, K. Wang, J. Liu, Y. Liu, Y. Hu, X. Zhang, M.T. Swihart, and P.N. Prasad A pilot study in non-human primates shows no adverse response to intravenous injection of quantum dots Nat. Nanotechnol. 7 2012 453 458
181. A.M. Derfus, A.M. Derfus, W.C.W. Chan, and S.N. Bhatia Probing the cytotoxicity of semiconductor quantum dots Nano Lett. 4 2004 11 18
182. Y. Su, Y. He, H. Lu, L. Sai, Q. Li, W. Li, L. Wang, P. Shen, Q. Huang, C. Fan, Y. Su, Y. He, H. Lu, L. Sai, Q. Li, W. Li, L. Wang, P. Shen, Q. Huang, and C. Fan The cytotoxicity of cadmium based, aqueous phase - synthesized, quantum dots and its modulation by surface coating Biomaterials 30 2009 19 25
183. P. Zrazhevskiy, M. Sena, and X. Gao Designing multifunctional quantum dots for bioimaging, detection, and drug delivery Chem. Soc. Rev. 39 2010 4326 4354
184. M.Z. Ahmad, S. Akhter, G.K. Jain, M. Rahman, S.A. Pathan, F.J. Ahmad, and R.K. Khar Metallic nanoparticles: Technology overview & drug delivery applications in oncology Expert Opin. Drug Deliv. 7 2010 927 942
185. M.K. Lai, C.Y. Chang, Y.W. Lien, and R.C. Tsiang Application of gold nanoparticles to microencapsulation of thioridazine J. Control. Release 111 2006 352 361